Johns Hopkins ABX Guide
Rifampin
Rifampin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- All forms of tuberculosis.
- Treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prosthetic valve endocarditis caused by staphylococci in combination with other agents (e.g. oxacillin/nafcillin, vancomycin) after blood cultures have cleared.
- Prosthetic joint infections following debridement and retention of the prosthesis or 1-stage exchange.
- Meningitis caused by penicillin and ceftriaxone resistant S. pneumoniae
- Non-tuberculous mycobacterial infections (e.g. leprosy, MAC)
- Brucellosis
- Bartonella infections
- Q-fever and rickettsialinfections
- Cutaneous leishmaniasis
- Legionella infections
- Anthrax infections
- NOTE: Rifampin is usually used in combination with other agents due to quick emergence of resistance if used as monotherapy.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- All forms of tuberculosis.
- Treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prosthetic valve endocarditis caused by staphylococci in combination with other agents (e.g. oxacillin/nafcillin, vancomycin) after blood cultures have cleared.
- Prosthetic joint infections following debridement and retention of the prosthesis or 1-stage exchange.
- Meningitis caused by penicillin and ceftriaxone resistant S. pneumoniae
- Non-tuberculous mycobacterial infections (e.g. leprosy, MAC)
- Brucellosis
- Bartonella infections
- Q-fever and rickettsialinfections
- Cutaneous leishmaniasis
- Legionella infections
- Anthrax infections
- NOTE: Rifampin is usually used in combination with other agents due to quick emergence of resistance if used as monotherapy.
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: June 5, 2017
Citation
Avdic, Edina, and Paul A Pham. "Rifampin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540483/all/Rifampin.
Avdic E, Pham PA. Rifampin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540483/all/Rifampin. Accessed March 8, 2021.
Avdic, E., & Pham, P. A. (2017). Rifampin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540483/all/Rifampin
Avdic E, Pham PA. Rifampin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2021 March 08]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540483/all/Rifampin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifampin
ID - 540483
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2017/06/05/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540483/all/Rifampin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
